No Data
No Data
Dian Diagnostics Group (300244.SZ): has repurchased 2.14% of its shares.
Dian Diagnostics Group (300244.SZ) announced that as of July 31, 2024, the company has repurchased a total of 13,406,000 shares of the company through a repurchase special securities account in a centralized bidding transaction, accounting for 2.14% of the company's current total share capital, with a maximum transaction price of 18.91 yuan/share and a minimum transaction price of 11.64 yuan/share. The total transaction amount was RMB 193,590,266 (excluding transaction fees). This repurchase complies with the company's share repurchase plan and relevant laws and regulations.
Investors Could Be Concerned With Dian Diagnostics GroupLtd's (SZSE:300244) Returns On Capital
Dian Diagnostics Group Co.,Ltd.'s (SZSE:300244) Market Cap up CN¥632m Last Week, Benefiting Both Retail Investors Who Own 43% as Well as Insiders
Dian Diagnostics Group (300244.SZ): has cumulatively repurchased 2.07% of shares.
Dian Diagnostics Group (300244.SZ) announced that as of July 2, 2024, the company has repurchased a total of 12,986,200 shares of its own stock through a repurchase special securities account, using the method of concentrated bidding transactions, accounting for 2.07% of the company's current total share capital. The highest fill price was 18.91 yuan/share, the lowest fill price was 11.64 yuan/share, and the total trading amount was RMB 189 million (excluding transaction costs).
Dian Diagnostics Group (300244.SZ) has repurchased a total of 10.3441 million shares, with a total cost of 157 million yuan.
Dian Diagnostics Group (300244.SZ) announced that as of June 30, 2024, the company will trade through centralized bidding...
Tao Jun, Deputy General Manager of Dian Diagnostics Group (300244.SZ), plans to increase shareholding with no less than RMB 1 million.
Dian Diagnostics Group (300244.SZ) announced that Tao Jun, Vice President and Secretary to the Board of Directors, plans to resign from July 2024.
No Data